Trinity shares drop 10% as Q1 profits fall

TRINITY BIOTECH shares slumped 10% yesterday after the Wicklow-based developer of clinical tests saw first-quarter pre-tax profits fall to $748,000 (€634,000), 60% less than the same period last year.

Trinity shares drop 10% as Q1 profits fall

Sales were broadly unchanged from the first three months of 2003 at $16.4 million and 6% ahead of sales in the previous quarter. But the bottom line suffered from increased selling and administrative costs, which jumped by $1.7m to $5.7m.

Chief financial officer Rory Nealon said the fall in pre-tax profits had been expected and was explained by the decision to take on 40 new sales staff in America.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €120 €60

Best value

Monthly €10€5 / month

More in this section

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited